Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - acetilcistein - peroralna raztopina - acetilcistein 20 mg / 1 ml - acetilcistein

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

raztopina za injiciranje - ropivakain

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - hidroksietilškrob; jabolčna kislina; kalcijev klorid; magnezijev klorid; natrijev acetat; natrijev klorid; kalijev klorid - raztopina za infundiranje - hidroksietilškrob 100 g / 1000 ml  jabolčna kislina0,67 g / 1000 ml  kalcijev klorid0,37 g / 1000 ml  magnezijev klorid0,2 g / 1000 ml  natrijev acetat3,27 g / 1000 ml  natrijev klorid6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; jabolčna kislina 0,67 g / 1000 ml  kalcijev klorid0,37 g / 1000 ml  magnezijev klorid0,2 g / 1000 ml  natrijev acetat3,27 g / 1000 ml  natrijev klorid6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; kalcijev klorid 0,37 g / 1000 ml  magnezijev klorid0,2 g / 1000 ml  natrijev acetat3,27 g / 1000 ml  natrijev klorid6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; magnezijev klorid 0,2 g / 1000 ml  natrijev acetat3,27 g / 1000 ml  natrijev klorid6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; natrijev acetat 3,27 g / 1000 ml  natrijev klorid6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; natrijev klorid 6,25 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; kalijev klorid 0,3 g / 1000 ml - hidroksietilškrob

Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pršilo za nos - beklometazon

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mazilo - kalcitriol

Evropska unija - slovenščina - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

shire pharmaceuticals ireland limited - lantan - žvečljiva tableta - lantan 1000 mg / 1 tableta - lantanov(iii) karbonat

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

shire pharmaceuticals ireland limited - lantan - žvečljiva tableta - lantan 750 mg / 1 tableta - lantanov(iii) karbonat

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

shire pharmaceuticals ireland limited - lantan - žvečljiva tableta - lantan 500 mg / 1 tableta - lantanov(iii) karbonat